Real-World Evaluation of TouchCare Nano in Pediatric Type 1 Diabetes

The goal of this observational study is to learn how well the TouchCare Nano automated insulin delivery system works and how safe it is for children and adolescents with type 1 diabetes in everyday medical care. The main questions this study aims to answer are: Does using the TouchCare Nano system help people with type 1 diabetes spend more time with their blood glucose in a healthy range? Are serious low blood sugar events or diabetic ketoacidosis uncommon while using this system in daily life? Participants are children and adolescents with type 1 diabetes who use the TouchCare Nano system as part of their regular diabetes care. Researchers will collect glucose sensor data and routine clinical information at the start of the study and during follow-up visits over about six months.

NCT Number	NCT07425912
Lead Sponsor	University of Campania Luigi Vanvitelli Collaborators: Ospedale Meyer, University of Messina
Conditions	Type 1 Diabetes Mellitus
Enrollment	76 participants
Start Date	2025-09-05
Primary Completion	2026-03-05 (estimated)
Study Completion	2026-03-15 (estimated)
Updated on ClinicalTrials.gov	2026-04-24